Evidence map›Paper›PMID 35056447›Full record

ArticleMedicina (Kaunas, Lithuania)2022

The Immunohistochemical Expression of the Serine and Arginine-Rich Splicing Factor 1 (SRSF1) Is a Predictive Factor of the Recurrence of Basal Cell Carcinoma: A Preliminary Study on a Series of 52 Cases.

Giuseppe Broggi, Davide Barbagallo, Francesco Lacarrubba, Anna Elisa Verzì, Giuseppe Micali, Michele Purrello, Rosario Caltabiano

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Giuseppe BroggiDepartment of Medical, Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Anatomic Pathology, University of Catania, 95123 Catania, Italy.ORCID 0000-0003-2576-6523
Davide BarbagalloDepartment of Biomedical and Biotechnological Sciences, Section of Biology and Genetics "Giovanni Sichel", University of Catania, 95123 Catania, Italy.ORCID 0000-0001-5331-4554
Francesco LacarrubbaDermatology Clinic, University of Catania, 95123 Catania, Italy.ORCID 0000-0002-0860-2060
Anna Elisa VerzìDermatology Clinic, University of Catania, 95123 Catania, Italy.
Giuseppe MicaliDermatology Clinic, University of Catania, 95123 Catania, Italy.
Michele PurrelloDepartment of Biomedical and Biotechnological Sciences, Section of Biology and Genetics "Giovanni Sichel", University of Catania, 95123 Catania, Italy.ORCID 0000-0001-8873-3660
Rosario CaltabianoDepartment of Medical, Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Anatomic Pathology, University of Catania, 95123 Catania, Italy.ORCID 0000-0001-8591-8010

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Basal Cell CarcinomaSerine-Arginine Splicing FactorsHumansImmunohistochemistryNeoplasm Recurrence, LocalRNA Splicing FactorsRNA Splicing FactorsSerine-Arginine Splicing FactorsSRSF1 protein, humanbasal cell carcinomaimmunohistochemical expressionlocal recurrencepredictive factorprognosisSRSF1

Identifiers

PMID35056447
PMCPMC8781844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.